Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This is a multicenter international observational prospective cohort study. The main questions it aims to answer are:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| ARDS+AKI | Diagnostic Test | according to the clinical practice Reanl doppler and VeXUS score will be performed |
| Measure | Description | Time Frame |
|---|---|---|
| cumulative incidence | Cumulative incidence of AKI within 7 days from the ARDS onset in demodulated and no-demodulated group | 1st april 2024 - 31st of january 2026 |
| Measure | Description | Time Frame |
|---|---|---|
| AKI14 | ) Incidence of AKI within 14 days from the ARDS onset in patient with and without IRVF demodulated or with different IRVF pattern | 1st april 2024 - 31st of january 2026 |
| AKIstage | VM, RIhil and RIintra, SI, VexUS values in AKI and no AKI patients and in the different AKI stage |
Not provided
Inclusion Criteria:
Exclusion Criteria:
No patient will be excluded from the study because of gender, race, ethnicity, or sexual preference.
Not provided
Not provided
Adult patients with diagnosis of ARDS admitted to intensive care unit and undergoing invasive mechanical ventilation (IMV).
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D058186 | Acute Kidney Injury |
| D012128 | Respiratory Distress Syndrome |
| ID | Term |
|---|---|
| D051437 | Renal Insufficiency |
| D007674 | Kidney Diseases |
| D014570 | Urologic Diseases |
| D052776 | Female Urogenital Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
on day #1, on day #3, on day #7 and on day #14 any 3 ml of urine and 3 ml of blood will be stocked
| 1st april 2024 - 31st of january 2026 |
| cross talk lung-kidney | invasive mechanical ventilation parameters (PEEP, Pressure of plateau, driving pressure and static compliance of the respiratory system) values and PaCO2 and PaO2/FiO2 values in the demodulated or in any IRVF pattern (continuous, pulsatility, biphasic and monophasic) | 1st april 2024 - 31st of january 2026 |
| CRRT | IRVF pattern (continuous, pulsatility, biphasic, monophasic), VM, RIhil and RIintra, IRVFhil, SI and VexUS at the beginning and at the discontinuation of CRRT | 1st april 2024 - 31st of january 2026 |
| incidence of failed exam | Percentage of exams successfully performed among the total of patients admitted to study | 1st april 2024 - 31st of january 2026 |
| CKD progression | Incidence of CKD Incidence of CKD Cumulative Incidence of CKD | 1st april 2024 - 31st of january 2026 |
| D005261 |
| Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
| D052801 | Male Urogenital Diseases |
| D008171 | Lung Diseases |
| D012140 | Respiratory Tract Diseases |
| D012120 | Respiration Disorders |